Clinical Trials Browser

Phase 2 × NSCLC × Radiotherapy × Clear all

NCT07413952 2026-02-17

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

Phase 2 Not yet recruiting

NSCLC

NCT05089916 2026-01-14

ROSE

Phase 2 Active not recruiting

NSCLC

NCT06865339 2025-09-10

TRIPL

Phase 2 Recruiting

NSCLC